After finalising the Daichii Sankyo deal in June Pharma major, Ranbaxy re-constituted its board of directors on Friday. The current Ranbaxy CEO and MD, Malvinder Singh Mohan, will assume the additional role of an Executive Chairman. Ranbaxy will remain a public listed company and will have five members on the board while Daichii will be represented by four members.
The motion claimed that Ranbaxy had failed to comply FDA standards.
http://www.ibnlive.com/news/us-court-withdraws-motion-against-ranbaxy/75321-7.html
Rudy Guiliani will help Ranbaxy resolve a US Food and Drug ban.
Ranbaxy-Daiichi Sankyo is still good despite the co's trouble with US laws.
http://www.ibnlive.com/news/ranbaxys-us-fda-case-may-hurt-other-indian-pharmas/73813-7.html
Sensex fell 45 points to 13473 and the Nifty lost 11 points at 4,064.
http://www.ibnlive.com/news/mkts-marginally-weak-ranbaxy-icici-bank-sterlite-plunge/73752-16.html
US FDA banned more than 30 generic drugs produced by Ranbaxy.
http://www.ibnlive.com/news/us-bans-ranbaxys-drugs-company-disappointed/73751-7.html
The Indian drug giant, Ranbaxy is a major maker of an AIDS generic drug.
http://www.ibnlive.com/news/us-fda-bans-dozens-of-ranbaxy-drugs/73728-7.html
Daiichi Sankyo to pump in Rs 10,000 crores to acquire stake in Ranbaxy.
http://www.ibnlive.com/news/daiichi-gets-green-signal-to-buy-into-ranbaxy/70490-7.html
A week rupee against the dollar has resulted in Ranbaxy's foreign exchange losses.
http://www.ibnlive.com/news/ranbaxy-q2-dips-beyond-forex-forecast/69843-7.html
It wants to know if FDA allowed Ranbaxy's faulty medicine deliberately.
http://www.ibnlive.com/news/us-cong-to-probe-fdas-ranbaxy-case/69021-7.html
India's largest pharma company is being investigated in the US for alleged fraud.
http://www.ibnlive.com/news/deal-with-daiichi-on-insists-ranbaxy-labs-chief/68981-7.html
Malvinder Singh says Daiichi Sankyo was aware of the US FDA issue before the deal was signed.
http://www.ibnlive.com/news/ranbaxy-allays-fears-over-daiichi-deal/68958-7.html
 |
|
